baby

Board Of Directors

Extracted from Annual Report 2014 and Bursa announcements.

Dr. Ho Choon Hou

Dr. Ho Choon Hou

Singaporean, aged 42, was appointed as Non-Independent Non-Executive Chairman of StemLife ("the Company") on 9 December 2013. He is also the Chairman of the Remuneration Committee and member of the Nomination Committee of the Company.
View Profile

Dr. Ho graduated with a Bachelor of Medicine & Bachelor of Surgery (Honours) from The University of Sheffield, as well as a Master of Medicine (Surgery) from the National University of Singapore. He also obtained his Master of Business Administration (Honours) from The University of Chicago (The Graduate School of Business).

Dr. Ho has vast experience in the financial and healthcare industries. He was a Registrar in the Department of General Surgery at the Tan Tock Seng hospital. He was also the Project Office Head and subsequently Deputy Director at the National Healthcare Group where he was involved in directing special projects and investments and held general management responsibilities.

He is the Non-Executive Chairman of Cordlife Group Limited, a company listed on the Stock Exchange of Singapore. Currently, Dr. Ho is a Principal at Southern Capital Group Limited, a private equity fund management firm since 2007. He is also an Independent Director of Advanced Holdings Ltd. and Mclean Technologies Bhd.

Dr. Ho does not have any family relationship with any other directors or major shareholders of the Company. He has no conflict of interest with the Company and has not been convicted of any offences within the past ten (10) years, other than minor traffic offences, if any. Dr. Ho has attended all six (6) Board Meetings of the Company held during the financial year.

Yap Yu Ming

Yap Yu Ming

Malaysian, age 46, was appointed as Independent Non-Executive Director of the Company on 16 February 2011. She is also the Chairperson of the Audit Committee and a member of the Nomination Committee of the Company.
View Profile

Ms. Yap is a Certified Practising Accountant of the Australian Society of Certified Practising Accountants (ASCPA), and is a registered Chartered Accountant with Malaysian Institute of Accountants (MIA). In 1990, she graduated from University of Newcastle, Australia, with a Bachelor of Commerce majoring in Accounting, and later on obtained a Master of Business Administration (MBA) from University of Malaya in 2000. She has 20 years of experience in finance and administration in various industries, mostly in property development and management.

Ms. Yap does not sit on the board of any other public listed company.

Ms. Yap does not have any family relationship with any other directors or major shareholders of the Company. She has no conflict of interest with the Company and has not been convicted of any offences within the past ten (10) years, other than minor traffic offences, if any.

Ms. Yap attended all six (6) Board Meetings of the Company held during the financial year.

YM Dr. Raja Abdul Malek bin Raja Jallaludin

YM Dr. Raja Abdul Malek bin Raja Jallaludin

Malaysian, age 69, was appointed as Non-Independent Non- Executive Director of the Company on 26th September 2012
View Profile

Dr. Raja Abdul Malek graduated from the University of Malaya in 1972. He then worked at the Kuala Lumpur General Hospital as well as the Faculty of Medicine at University Kebangsaan Malaysia (UKM). In late 1975, he went into private medical practice and was a senior partner of Drs. Catterall, Khoo, Raja Malek & Partners one of the most senior medical group practices, overseeing local and expatriate healthcare in the Klang Valley.

Dr. Raja Abdul Malek also has vast experience in the pharmaceutical world and has actively been involved since 1984 as the Medical Director of Parke Davis-Warner Lambert, and later, Pfizer when these two incorporations merged. However, it was in 2003 that Dr. Raja Abdul Malek joined HOE Pharmaceuticals/HOE Pharma Holdings (now a subsidiary of TAISHO Pharmaceutical, Japan) as Director for Medical and Scientific Affairs, a position that he holds to this day.

His other directorships in public and private companies include ABB Trustee Berhad and AFFIN Bank Berhad. He has more than 20 years of varied experience associated with the medical, sports, banking and pharmaceutical industries.

His other directorships in public and private companies include ABB Trustee Berhad, AFFIN Bank Berhad, Boustead Plantation Berhad. He has more than 40 years of varied experience associated with the medical, sports, banking and pharmaceutical industries.

Dr. Raja Abdul Malek does not have any family relationship with any other directors or major shareholders of the Company. He has no conflict of interest with the Company and has not been convicted of any offences within the past ten (10) years, other than minor traffic offences, if any.

Dr. Raja Abdul Malek has attended four (4) out of the six (6) Board Meetings of the Company held during the financial year.

Dato' Mark William Ling Lee Meng

Dato' Mark William Ling Lee Meng

Malaysian, aged 52, was appointed as Independent Non-Executive Director of the Company on 9 December 2013. He is also the Chairman of the Nomination Committee and a member of the Audit Committee and Remuneration Committee of the Company.
View Profile

Upon completing his high school education at The Southport School in Australia, Dato' Mark started his career in the family business at Kong Ming Bank Berhad. He was appointed as Marketing Director where he was involved in project finance transactions in a number of industry sectors. Dato' Mark left the banking industry and focused on the development of green field power projects in the Asia Pacific region.

Dato' Mark was appointed as Strategic Planning Advisor by Powergen International and was responsible to create proprietary deal flow to develop power project portfolios in the Asia Pacific region. He was then set up a private equity firm specialising in the energy sectors and has been involved with strategic investments focused primarily in the emerging economies in the Asia Pacific and Africa regions.

Dato' Mark is currently an Independent Non-Executive Director of MClean Technologies Berhad and sits as the Chairman of the Nomination Committee, Remuneration Committee and Audit Committee of MClean. On September 1, 2014, he was appointed as President and Executive Directors of Edra Global Energy Bhd on 1st October 2014.

Dato' Mark does not have any family relationship with any other directors or major shareholders of the Company. He has no conflict of interest with the Company and has not been convicted of any offences within the past ten (10) years, other than minor traffic offences, if any. Dato' Mark has attended all six (6) Board Meetings of the Company held during the financial year.

Sahba Phillipe Christiane Saint-Claire

Sahba Phillipe Christiane Saint-Claire

Australian, age 50, was appointed as Independent Non-Executive Director of the Company on 18 March 2014.
View Profile

Mr. Sahba Saint-Claire is an experienced executive with over 25 years of experience gained from working in senior regional and global roles with leading financial institutions. He has worked with Standard Chartered Bank, Development Bank of Singapore, JP Morgan Investment Bank and Westpac Bank - mainly in backoffice systems, technology applications and infrastructure on CRM, equities, derivatives, research and the financial markets.

He started his career with Westpac as a systems analyst, later as a consultant and employment with the aforesaid financial institutions before setting up his own company named AIAS Solutions in July 2013 in Singapore, providing advice to financial institutions and their software and service providers.

Mr. Sahba Saint-Claire holds a Bachelor of Science degree in Pure Mathematics and Computer Science from the University of Sydney in Australia.

Mr. Sahba Saint-Claire does not sit on the board of any other public listed company.

Mr. Sahba Saint-Claire does not have any family relationship with any other directors or major shareholders of the Company. He has no conflict of interest with the Company and has not been convicted of any offences within the past ten (10) years, other than minor traffic offences, if any.

Mr. Sahba Saint Claire has attended three (3) out of six (6) Board Meetings of the Company.

Sophian Bin Abdul Rahman

Sophian Bin Abdul Rahman

Singaporean, age 40, was appointed as Executive Director of the company on 11 November 2015. Mr. Sophian is currently StemLife Berhad's Acting CEO.
View Profile

Mr. Sophian Bin Abdul Rahman ("Mr. Sophian") is a recipient of Singaporean government's Economic Development Board (EDB) Scholarship to pursue a Masters in Aeronautical Engineering from Imperial College of London.

Upon graduation, Mr Sophian served in EDB (Singapore's equivalent of MIDA) and International Enterprise (IE) Singapore (Singapore's equivalent of MATRADE). Prior to joining StemLife Berhad, Mr Sophian was with CapitaLand, one of Southeast Asia's largest real estate developers, where he was a key member in starting up several initiatives in the Middle East and attracted institutional investors to set up private capital partnerships with the CapitaLand Group. He also serves on the board of governors of Temasek Polytechnic in Singapore.

Hoo Yee Fong

Hoo Yee Fong

Malaysian, age 42, was appointed as Alternate Director of the Company on 11 November 2015. Ms. Hoo Yee Fong is currently StemLife Berhad's Acting CFO.
View Profile

Ms. Hoo Yee Fong ("Ms. Hoo") graduated from University of Malaya in 1997 with a degree in Accounting. She is a member of Malaysian Institute of Accountants (MIA) and Chartered Financial Analyst (CFA) Institute.

Ms. Hoo has approximately 18 years of experience in finance and administration in various industries. She joined StemLife Berhad in June 2014 and prior to that she was the Financial Controller of a diversified group based in Singapore.

back to home